Aging is the most prominent risk factor for many diseases, which is considered to be a complicated biological process. The rate of aging depends on the effectiveness of important mechanisms such as the protection of DNA from free radicals, which protects the structural and functional integrity of cells and tissues. In any organism, not all organs may age at the same rate. Slowing down primary aging and reaching maximum lifespan is the most basic necessity. In this process, it may be possible to slow down or stabilise some diseases by using the compounds for both dietary and pharmacological purposes. Natural compounds with antioxidant and anti-inflammatory effects, mostly plant-based nutraceuticals, are preferred in the treatment of age-related chronic diseases and can also be used for other diseases. An increasing number of long-term studies on synthetic and natural compounds aim to elucidate preclinically and clinically the mechanisms underlying being healthy and prolongation of life. To delay age-related diseases and prolong the lifespan, it is necessary to take these compounds with diet or pharmaceuticals, along with detailed toxicological results. In this review, the most promising and utilised compounds will be highlighted and it will be discussed whether they have toxic effects in short/long-term use, although they are thought to be used safely.

The red yeast Phaffia rhodozyma is considered as a useful source of astaxanthin (ASX) which is a carotenoid pigment widely used in the feed industry. Poultry cannot synthesise carotenoids, so they must obtain these pigments from diet supplementation with sources such as red yeast, as a source of ASX. Astaxanthin has health benefits including the protection against oxidative damage in cells, enhancement of the immune response and protection against diseases by scavenging oxygen free radicals. It has activities approximately 10 times stronger than that of other carotenoids and 100 times greater than α-tocopherol against reactive oxygen species. In recent years, Phaffia rhodozyma has become an important microorganism for its use in both the pharmaceutical industries and food. Dietary Phaffia rhodozyma addition at the level of 10 and 20 mg/kg in broiler diets positively increased weight gain by 4.12 and 6.41% respectively. The inclusion of ASX rich red yeast (100 mg/kg) in broiler diets for 14 days improved T-cell proliferation and IgG production by 111.1 and 34.6% respectively. However, the optimum level or feeding duration of dietary ASX rich red yeast addition for enhancing poultry productive, physiological and immunological responses has not been determined.

The Indian Western continental shelf (IWCS) is amongst the most productive regions of the world, being noteworthy for upwelling (south-west monsoon) and downwelling (north-east monsoon) that tunes the water biogeochemistry. The present study provides baseline information on temporal variation of in situ copepod gut pigments from IWCS. The copepods were collected between November 2011 and October 2013 and gut pigment contents and composition were estimated using the gut fluorescence method. Results revealed that copepods procured high gut pigment content in monsoon that coincided with ambient water pigment credited to discrete upwelling. Fluorometric analyses of copepod orders revealed presence of gut chlorophyll a (Chl a) throughout the study with highest gut Chl a (0.31 ± 0.25 ng copepod−1; N = 21) and total gut pigments (2.01 ± 2.15 ng copepod−1; N = 21) recorded in Calanoida. Consecutively, Calanoida and Poecilostomatoida chiefly consumed autotrophic biomass that was evident from presence of canthaxanthin and astaxanthin as dominant gut pigments. Interestingly, the marker pigment of Cryptophyceae was present only in Calanoida during monsoon and post-monsoon. Collectively these results conclude that copepods predominantly showed omnivory with discrete temporal variability by grazing upon autotrophic biomass that in turn probably supports the fishery.

Non-alcoholic fatty liver disease (NAFLD) is significantly associated with hyperlipidaemia and oxidative stress. We have previously reported that astaxanthin (ASTX), a xanthophyll carotenoid, lowers plasma total cholesterol and TAG concentrations in apoE knockout mice. To investigate whether ASTX supplementation can prevent the development of NAFLD in obesity, male C57BL/6J mice (n 8 per group) were fed a high-fat diet (35 %, w/w) supplemented with 0, 0·003, 0·01 or 0·03 % of ASTX (w/w) for 12 weeks. The 0·03 % ASTX-supplemented group, but not the other groups, exhibited a significant decrease in plasma TAG concentrations, suggesting that ASTX at a 0·03 % supplementation dosage exerts a hypotriacylglycerolaemic effect. Although there was an increase in the mRNA expression of fatty acid synthase and diglyceride acyltransferase 2, the mRNA levels of acyl-CoA oxidase 1, a critical enzyme in peroxisomal fatty acid β-oxidation, exhibited an increase in the 0·03 % ASTX-supplemented group. There was a decrease in plasma alanine transaminase (ALT) and aspartate transaminase (AST) concentrations in the 0·03 % ASTX-supplemented group. There was a significant increase in the hepatic mRNA expression of nuclear factor erythroid 2-related factor 2 and its downstream genes, which are critical for endogenous antioxidant mechanism, in the 0·03 % ASTX-supplemented group. Furthermore, there was a significant decrease in the mRNA abundance of IL-6 in the primary splenocytes isolated from the 0·03 % ASTX-supplemented group upon lipopolysaccharide (LPS) stimulation when compared with that in the splenocytes isolated from the control group. In conclusion, ASTX supplementation lowered the plasma concentrations of TAG, ALT and AST, increased the hepatic expression of endogenous antioxidant genes, and rendered splenocytes less sensitive to LPS stimulation. Therefore, ASTX may prevent obesity-associated metabolic disturbances and inflammation.

In Antarctica, mass accumulations of psychrophilic algae cause striking phenomena like green, orange, or red snow. This occurs during summer, when coastal snowfields start to melt, become waterlogged and photoautotrophs can thrive. Chloromonas polyptera (Fritsch) Hoham, Mullet & Roemer is a unicellular species that causes orange snow in the vicinity of penguin rockeries. It has been recognized for many decades because of the distinct habitat and the characteristic morphology of cysts with elongated flanges on the outer cell wall. However, closer investigations concerning the ecology or physiology have been sparse so far. Field material was collected from two sites on the Antarctic Peninsula to find out more about metabolic and cellular strategies. The results were compared with a closely related species from high alpine locations, Chloromonas nivalis (Chodat) Hoham & Mullet. Despite the geographical distance, C. polyptera shares several physiological strategies with the alpine relative, such as the formation of cyst stages, saccharose and glycerol as main soluble carbohydrates and the abundant accumulation of the carotenoid astaxanthin. Moreover, photosynthesis is adapted to temperatures of about 1°C. The molecular phylogeny confirmed a close relationship of C. polyptera to other Chloromonas species isolated from snow. Chloromonas polyptera seems to be exclusive to coastal Antarctic ecosystems influenced by animal nutrient input.

Penaeus monodon (mean initial wet weight 1·19 (se 0·01) g) were fed seven diets in triplicate: a control diet (D1) without carotenoids; three diets formulated to supply 0·1 % astaxanthin alone (D2), 0·2 % astaxanthin alone (D3), and a combination of 0·1 % astaxanthin and 1 % cholesterol (D4); three diets with 0·07 % canthaxanthin alone (D5), 0·13 % canthaxanthin alone (D6), and a combination of 0·07 % canthaxanthin and 1 % cholesterol (D7). Weight gain (WG, %), specific growth rate (SGR, %/d) and survival were chosen as parameters of shrimp growth performance. Total antioxidant status (TAS), superoxide dismutase (SOD), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were chosen as indices of shrimp plasma antioxidant capacity. Meanwhile, digestibility, retention efficiency and tissue carotenoids were also investigated to determine the additive effect of cholesterol on the efficiency of astaxanthin and canthaxanthin. After 74 d rearing, WG and SGR of shrimp fed D2–D4 and D7 were higher than those of shrimp fed D1 (P < 0·05). Shrimp fed D4 had the highest survival. The apparent digestibility coefficients (ADC) of astaxanthin in D2–D4 were higher than those of canthaxanthin in D5–D7 (P < 0·05). Although ADC of astaxanthin were quite high (>98 %) in D2–D4 and no differences were found among them (P>0·05), the carotenoid retention efficiencies in the whole body, muscle and shell (D2–D3 treatments) were considerably low; however, cholesterol supplementation significantly improved the carotenoid retention efficiencies in the whole body, muscle and shell (D4 treatment). Accordingly, the addition of cholesterol also significantly enhanced the carotenoid contents of tissues. Shrimp fed supplemented carotenoid diets (D2–D7) had higher TAS and lower SOD, ALT and AST than shrimp fed D1 (P < 0·05). A low dissolved oxygen stress test was conducted for 7 d after the rearing trial and shrimp survival was also compared among the treatments. The survival of shrimp fed the diets supplemented with astaxanthin or canthaxanthin was higher than that of shrimp fed D1 during the stress test (P < 0·05). In conclusion, all data suggested that astaxanthin was better than canthaxanthin as the dietary carotenoid source in the commercial diet of P. monodon, and the supplement of cholesterol could positively enhance the efficiency of astaxanthin and canthaxanthin.

Phospholipid hydroperoxides (PLOOH) accumulate abnormally in the erythrocytes of dementia patients, and dietary xanthophylls (polar carotenoids such as astaxanthin) are hypothesised to prevent the accumulation. In the present study, we conducted a randomised, double-blind, placebo-controlled human trial to assess the efficacy of 12-week astaxanthin supplementation (6 or 12 mg/d) on both astaxanthin and PLOOH levels in the erythrocytes of thirty middle-aged and senior subjects. After 12 weeks of treatment, erythrocyte astaxanthin concentrations were higher in both the 6 and 12 mg astaxanthin groups than in the placebo group. In contrast, erythrocyte PLOOH concentrations were lower in the astaxanthin groups than in the placebo group. In the plasma, somewhat lower PLOOH levels were found after astaxanthin treatment. These results suggest that astaxanthin supplementation results in improved erythrocyte antioxidant status and decreased PLOOH levels, which may contribute to the prevention of dementia.

Astaxanthin is a carotenoid with antioxidant, anti-cancer and anti-inflammatory properties. The pharmacokinetics of astaxanthin after its intravenous (5, 10, and 20 mg/kg) and oral (100 and 200 mg/kg) administration and its first-pass extraction ratios after its intravenous, intraportal or intragastric (20 mg/kg) administration were evaluated in rats. The pharmacokinetic parameters of astaxanthin were dose dependent after its intravenous administration, due to the saturable hepatic metabolism of astaxanthin, but dose independent after oral administration. The gastrointestinal absorption of astaxanthin followed the flip-flop model. The hepatic and gastrointestinal first-pass extraction ratios of astaxanthin were approximately 0·490 and 0·901, respectively. Astaxanthin was metabolised primarily by hepatic cytochrome P-450 1A1/2 in rats. Astaxanthin was unstable up to 4 h incubation in four rat gastric juices and up to 24 h incubation in various buffer solutions having a pH of 1–13. The tissue/plasma ratios of astaxanthin at 8 and 24 h after its oral administration (100 mg/kg) were greater than unity for all tissues studied, except in the heart, at 8 h, indicating that the rat tissues studied had high affinity for astaxanthin.

The objective of the present study was to investigate the bioavailability and the configurational isomer distribution of the carotenoid astaxanthin (AST) in human plasma after ingestion of wild (Oncorhynchus spp.) and aquacultured (Salmo salar) salmon. In a randomised and double-blind trial, twenty-eight healthy men consumed 250 g wild or aquacultured salmon daily for 4 weeks which provided 5 μg AST/g salmon flesh. The plasma AST concentrations as well as the isomer distribution were measured by HPLC using a reversed and a chiral stationary phase. After 6 d of intervention with salmon, plasma AST concentrations reached a plateau of 39 nmol/l after consumption of wild salmon and of 52 nmol/l after administration of aquacultured salmon. At days 3, 6, 10 and 14 – but not at day 28 – the AST concentrations in human plasma were significantly greater after ingestion of aquacultured salmon. After administration of wild salmon, the (3S,3′S) isomer predominated in plasma (80 %), whereas after intake of aquacultured salmon the meso form (3R,3′S) prevailed (48 %). Therefore, the AST isomer pattern in human plasma resembles that of the ingested salmon. However, after consumption of both wild and aquacultured salmon for 28 d the relative proportion of the (3S,3′S) isomer was slightly higher and the (3R,3′R) form lower in human plasma compared with the isomer distribution in salmon flesh. A selective process of isomer absorption could be responsible for the observed differences in the relative proportions of the (3S,3′S) and (3R,3′R) isomers in human plasma compared with salmon flesh.

Flagellates of Haematococcus pluvialis accumulate secondary carotenoids (mainly astaxanthin and its esters) under nitrogen deficiency in combination with exposure to stronger light. Our cultivation scheme allows the characterization of metabolic activities during the accumulation process without interference by formation of the resting state (aplanospores). The highest rate of secondary carotenoid biosynthesis (0·046 h−1) was observed almost simultaneously with the highest rates of cell division (0·027 h−1) and of chlorophyll biosynthesis (0·015 h−1) after 1·5 days of exposure to nitrogen limitation and higher irradiance. Photosynthetic activity was studied by oxygen evolution and chlorophyll fluorescence measurements; changes in protein components of the photosynthetic apparatus were quantified by gel electrophoresis and immunoblot analysis. Accumulation of secondary carotenoids was accompanied by an increase in photosynthetic productivity expressed on a unit chlorophyll basis. Changes in the photosynthetic apparatus occurring mainly during the first 2 days of exposure to nitrogen limitation and stronger light can be interpreted as acclimation to the increased cultivation irradiance. Photoprotective action of secondary carotenoids as a ‘sunshade’ was demonstrated in red flagellates exhibiting a lower blue-light-induced decrease in photosystem II efficiency as compared with red actinic light.

The reproductive performance of pond tiger shrimp given astaxanthin (100 mg·kg−1) and/or vitamin A (20 000 IU·kg−1) for 61 d in tanks was assessed in a 2 × 2 factorial experiment in a completely randomized design. Tissue carotenoid (total carotenoid; astaxanthin free form. AF; monoester, AM; diester, AD) was analyzed using high performance liquid chromatography. The gonad index (GI) of shrimps fed diets with astaxanthin and/or vitamin A (3.05 ± 0.11 to 3.30 ± 0.17) were significantly higher than shrimps not fed any supplement (2.24 ± 0.17). A significant interaction between astaxanthin and vitamin A for ovarian development and spawning was detected (GI, 3.18 ± 0.14). The ovarian total carotenoid (10.85 ± 1.52 μg·g−1) and astaxanthin (AF, 7.65 ± 1.43 μg·g−1; AM, 0.63 ± 0.12 μg·g−1) content of shrimps fed a diet with astaxanthin supplement were significantly higher than those without. In shrimps fed diets with and without vitamin A, no differences in ovarian total carotenoid (9.38 ± 0.58 μg·g−1) and AF (8.12 ± 1.55 μg·g−1) content were observed except for AM (0.64 pm 0.15 μg·g−1) content. In contrast, the ovarian AD level was significantly higher (1.14 ± 0.3 μg·g−1) in shrimps fed diets with both supplements compared to other diets. A significant interaction between astaxanthin and vitamin A was detected for AD storage. In the hepatopancreas of shrimps fed diets with or without astaxanthin or vitamin A, no significant differences in AF and AM content was observed. On the other hand, the AD (4.92 ± 1.3 μg·g−1) level in the hepatopancreas of shrimps fed diet with vitamin A was significantly higher than those without. These results suggest the involvement of astaxanthin in P. monodon reproduction and its need for inclusion in broodstock diets. Supplementation of vitamin A to broodstock diet of P. monodon appears to enhance its ovarian development and spawning.

The combination of nitrogen deprivation and increased cultivation light intensity resulted in the synthesis of secondary carotenoids in flagellates of Haematococcus lacustris. The pigment pattern was characterized by high-pressure liquid chromatography analysis during the accumulation period and in response to inhibitors of carotenoid biosynthesis (diphenylamine, norflurazon and tetcyclacis). Diphenylamine treatment resulted in (i) a decrease in ketocarotenoids and (ii) an accumulation of β-carotene and zeaxanthin due to inhibition of the β-carotene oxygenase. Our results indicate that astaxanthin synthesis in H. lacustris follows the biosynthetic pathway elucidated in the marine bacterium Agrobacterium aurantiacum.